0001209191-21-067914.txt : 20211203 0001209191-21-067914.hdr.sgml : 20211203 20211203172046 ACCESSION NUMBER: 0001209191-21-067914 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211201 FILED AS OF DATE: 20211203 DATE AS OF CHANGE: 20211203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McHugh Miles W CENTRAL INDEX KEY: 0001366227 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 211471181 MAIL ADDRESS: STREET 1: C/O ACCRETIVE HEALTH, INC. STREET 2: 401 N. MICHIGAN AVE, SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-01 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001366227 McHugh Miles W C/O HORIZON THERAPEUTICS PLC, 70 SAINT STEPHEN?S GREEN DUBLIN L2 D02 E2X4 IRELAND 0 1 0 0 Sr VP & Princ. Acctg Officer Ordinary Shares 2021-12-01 4 M 0 79484 22.14 A 116005 D Ordinary Shares 2021-12-01 4 S 0 79484 106.62 D 36521 D Stock Option (Right to Buy) 22.14 2021-12-01 4 M 0 79484 0.00 D 2025-03-22 Ordinary shares 79484 0 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option is fully vested and exercisable. /s/ Miles W. McHugh 2021-12-03